Bicycle Therapeutics appoints Felix Baker to board; Jordan resigns, becomes consultant

BICYCLE THERAPEUTICS PLC

Veronica Jordan resigned as director April 17; will serve as consultant at GBP 12,000/yr for 2-year term, equity continues vesting.
Felix J. Baker appointed as Class I director effective April 18; will sit on Nominating and Scientific committees.
BBA Funds (Baker's affiliates) obtained registration rights for resale of ordinary shares/ADSs; company to file registration within 60 days of demand.
BBA Funds hold >10% of outstanding shares; Baker is a managing member of Baker Bros. Advisors GP.

item 1.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Felix J. Baker

Class I Director

BCYC · BICYCLE THERAPEUTICS PLC

Effective: 2024-04-18
Filed: April 18, 2024, 7:59 PM ET

On April 16, 2024, the Board , upon the recommendation of the Nominating and Corporate Governance Committee of the Company (the “ NCGC ”), appointed Felix J. Baker, Ph.D. to the Board, effective as of April 18, 2024, New York City time.

Departed

Veronica Jordan

Class I Director

BCYC · BICYCLE THERAPEUTICS PLC

Effective: 2024-04-17
Successor: Felix J. Baker
Filed: April 18, 2024, 7:59 PM ET

On April 16, 2024, Veronica Jordan, Ph.D. notified the Board of Directors of the Company (the “ Board ”) of her decision to resign as a Class I director of the Company and as the Chair of the Compensation Committee of the Board and as a member of the Audit Committee of the Board, effective as of the close of business on April 17, 2024, New York City time.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Felix J. Baker was appointed as Class I Director at BICYCLE THERAPEUTICS PLC.

Action: appointed
Role: Class I Director

Exact text from the filing

On April 16, 2024, the Board , upon the recommendation of the Nominating and Corporate Governance Committee of the Company (the “ NCGC ”), appointed Felix J. Baker, Ph.D. to the Board, effective as of April 18, 2024, New York City time.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Veronica Jordan resigned as Class I Director at BICYCLE THERAPEUTICS PLC.

Action: resigned
Role: Class I Director

Exact text from the filing

On April 16, 2024, Veronica Jordan, Ph.D. notified the Board of Directors of the Company (the “ Board ”) of her decision to resign as a Class I director of the Company and as the Chair of the Compensation Committee of the Board and as a member of the Audit Committee of the Board, effective as of the close of business on April 17, 2024, New York City time.

View on SEC.gov

BICYCLE THERAPEUTICS PLC filing history →

Source: SEC EDGAR

accession 0001104659-24-048576

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.